drugset / Trial / NCT00902161
A Single-Dose Crossover Study of MK0893 in Patients With Type 2 Diabetes (0893-019 AM4)(COMPLETED)
RandomizedCrossoverDouble-blindTreatment
Summary
This study will assess the effect of combined treatment with MK0893 plus propranolol versus placebo plus propranolol on hypoglycemia.
Timeline
- Start
- 2009-05
- Primary completion
- 2009-10
- Completion
- 2009-11
Outcome
Met primary endpoint
registry MK0893 + Propanolol vs Placebo + Propanolol; p = 0.005; Least Squared Mean Treatment Difference 32 (95% CI 15 to 49) NCT00902161 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MK-0893 | Small molecule | 1000 mg | — |
| Background | Propranolol | Small molecule | 80 mg | — |